S100A9 and vitiligo: With the dual guarantee of multivariate logistic regression and ROC analysis, we found that serum HMGB1, S100B, and S100A9 can efficiently discriminate between patients with stable and active vitiligo, and can be used as potential biomarkers for the prediction of disease activity.